Abstract
Background
Genetic variants for IgE-mediated peanut allergy are yet to be fully characterized and to date only one genome-wide association study (GWAS) has been published.
Objective
To identify genetic variants associated with challenge proven peanut allergy.
Methods
We carried out a GWAS comparing 73 infants with challenge-proven IgE-mediated peanut allergy against 148 non-allergic infants (all ~ 1 year old). We tested a total of 3.8 million single nucleotide polymorphism (SNPs), as well as imputed HLA alleles and amino acids. Replication was assessed by de novo genotyping in a panel of additional 117 cases and 380 controls, and in silico testing in two independent GWAS cohorts.
Results
We identified 21 independent associations at P ≤ 5x10-5 but were unable to replicate these. The most significant HLA association was the previously reported amino acid variant located at position 71, within the peptide-binding groove of HLA-DRB1 (P = 2x10-4). Our study therefore reproduced previous findings for the association between peanut allergy and HLA-DRB1 in this Australian population.
Conclusions & Clinical Relevance
Genetic determinants for challenge proven peanut allergy include alleles at the HLA-DRB1 locus.
This article is protected by copyright. All rights reserved.
http://ift.tt/2gk7Pgr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου